Cerebral and coronary vascular effects of a symmetrical N,N'-disubstituted hexahydrodiazepine.
D000241:Adenosine / Q000494:pharmacology; D000818:Animals; D001011:Aorta / Q000187:drug effects; D001381:Azepines / Q000494:pharmacology*; D001565:Benzoates / Q000494:pharmacology; D001794:Blood Pressure / Q000187:drug effects; D002560:Cerebrovascular Circulation / Q000187:drug effects*; D003326:Coronary Circulation / Q000187:drug effects*; D004285:Dogs; D004347:Drug Interactions; D004357:Drug Synergism; D006168:Guinea Pigs; D006325:Heart Atria / Q000187:drug effects; D006339:Heart Rate / Q000187:drug effects; D006614:Hindlimb / Q000098:blood supply; D066298:In Vitro Techniques; D007668:Kidney / Q000098:blood supply; D008297:Male; D009119:Muscle Contraction / Q000187:drug effects; D010477:Perfusion; D012039:Regional Blood Flow / Q000187:drug effects; D014665:Vasodilator Agents / Q000494:pharmacology*
D001381:Azepines; D001565:Benzoates; D014665:Vasodilator Agents; D000241:Adenosine